Multiple sclerosis is a disease of the immune system that affects the central nervous system, or brain and spinal cord. A form of auto-immune disease, the disease damages the nerves and may affect separate or multiple elements of the body, causing pain and severe limitation to movement, ability, and quality of life.
The disease causes damage and destruction to the protective covering (myelin sheath) that surrounds nerve cells. Damage to the myelin sheath severely slows or interrupts nerve impulses, causing intense pain and inability to control movement. Individuals diagnosed with multiple sclerosis experience episodes of inflammation that cause the body's immune cells to attack the nervous system.
Stem Cell Technologies and Multiple Sclerosis
In recent months, treating a patient who has been diagnosed with multiple sclerosis with their own immune system stem-cells has shown promise in some clinical trials where severe nerve cell injury has not however occurred.
Clinical trials developed at the Northwestern University Feinberg Faculty Of Medication in Chicago removed patient's stem-cells in bone marrow, injected chemicals to destroy broken immune cells and then re-injected the stem-cells into the patient's bodies. 3 years later, not one of the twenty three people who engaged within the clinical trials experienced further deterioration, while 17 of them showed some improvement.
In additional studies, adult stem-cells that have been taken from a patient's fatty tissues have shown promise in reducing clinical manifestation of the disease process. Clinical trials using mesenchymal stem-cells showed improvement, according to the Journal Of Translational Medication, describing studies performed at the University of California San Diego. Mesenchymal stem-cells are shown to scale back or stop immune activation of cells and target specific areas where tissue harm had occurred.
Use of stem-cell technologies to treat multiple sclerosis is intended to literally "reset" immune system perform and is that specialize in reversing or slowing early diagnosis of multiple sclerosis. Recently, a world symposium (Stem Cell Transplantation in Multiple Sclerosis: Sharing The Expertise) was conducted in Moscow, Russia to discuss views in new methods of treating multiple sclerosis through autologous hematopoietic (bone marrow stem-cells that may 'morph' or turn out to be a variety of stem cell varieties)stem-cell transplantation combined with high dose immunosuppressive therapies.
The Future of Treatment
In recent months, Brainstorm Cell Therapeutics, Inc., has developed a therapeutic approach for potential treatment of multiple muscular conditions including Parkinson's disease, ALS and multiple-sclerosis. Multiple sclerosis treatments are currently being conducted on mouse models, with results published in the Journal Of Molecular Neuroscience.
Edges of such treatment offer individuals diagnosed with multiple-sclerosis, particularly those diagnosed early, with renewed neural and muscular perform, reduced symptoms and enhanced quality of life. News articles abound with stories of varied stages of recovery of people who have undergone stem-cell treatment for multiple-sclerosis, some who have even recovered the power to walk.
From Australia to Europe, individuals undergoing clinical trials of stem-cell therapy are showing a 60 to eighty% chance of slowing the disease process, while some might relish the advantages of reversing the disease in its entirety. While there's no cure as yet for multiple-sclerosis, stem-cell treatments that focus on repair and regeneration of the central nervous system offer hope to people littered with neural injury round the globe.
Author Resource:-
Coye Daniels has been writing articles online for nearly 2 years now. Not only does this author specialize in diseases,you can also check out his latest website about:
Make Your Own Doll Which reviews and lists the best
![[Valid RSS feed]](http://www.healthandwealth4you.com/images/icon_Rss.png "XML Feed For RSS"){kind=icon}
Category Rss Feed
Print This Article
Add To Favorites
